Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Proia

Showing results (41-50 of 89) with videos related to

Pageof 9
Sort By:
Mycoses|September 23, 2015
Cerebrospinal fluid Coccidioides antigen testing in the diagnosis and management of central nervous system coccidioidomycosisDavid M Bamberger, Brian S Pepito, Laurie A Proia, et al.
Nature|May 27, 2015
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatmentE M Alexandrova, A R Yallowitz, D Li, et al.
Molecular Cancer Therapeutics|January 9, 2014
Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespibJaime Acquaviva, Donald L Smith, John-Paul Jimenez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Phialemonium: an emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infectionLaurie A Proia, Mary K Hayden, Patricia L Kammeyer, et al.
Haematologica|November 6, 2001
Thrombotic thrombocytopenic purpura: prospective neurologic, neuroimaging and neurophysiologic evaluationG Meloni, A Proia, G Antonini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantationG Meloni, A Proia, V Guerrisi, et al.
Oncotarget|September 10, 2016
STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcomaChristine M Heske, Arnulfo Mendoza, Leah D Edessa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2016
Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with ChemoradiationYifan Wang, Hui Liu, Lixia Diao, et al.
Cell Death & Disease|September 12, 2014
UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespibH Landmann, D A Proia, S He, et al.
Plos One|December 5, 2014
Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in miceZachary B Smithline, Anna S Nikonova, Harvey H Hensley, et al.
Pageof 9

Showing results (41-50 of 89) with videos related to

Sort By:
Pageof 9
Mycoses|September 23, 2015
Cerebrospinal fluid Coccidioides antigen testing in the diagnosis and management of central nervous system coccidioidomycosisDavid M Bamberger, Brian S Pepito, Laurie A Proia, et al.
Nature|May 27, 2015
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatmentE M Alexandrova, A R Yallowitz, D Li, et al.
Molecular Cancer Therapeutics|January 9, 2014
Overcoming acquired BRAF inhibitor resistance in melanoma via targeted inhibition of Hsp90 with ganetespibJaime Acquaviva, Donald L Smith, John-Paul Jimenez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Phialemonium: an emerging mold pathogen that caused 4 cases of hemodialysis-associated endovascular infectionLaurie A Proia, Mary K Hayden, Patricia L Kammeyer, et al.
Haematologica|November 6, 2001
Thrombotic thrombocytopenic purpura: prospective neurologic, neuroimaging and neurophysiologic evaluationG Meloni, A Proia, G Antonini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 6, 2001
Acute myeloid leukemia and lung cancer occurring in a chronic lymphocytic leukemia patient treated with fludarabine and autologous peripheral blood stem-cell transplantationG Meloni, A Proia, V Guerrisi, et al.
Oncotarget|September 10, 2016
STA-8666, a novel HSP90 inhibitor/SN-38 drug conjugate, causes complete tumor regression in preclinical mouse models of pediatric sarcomaChristine M Heske, Arnulfo Mendoza, Leah D Edessa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2016
Hsp90 Inhibitor Ganetespib Sensitizes Non-Small Cell Lung Cancer to Radiation but Has Variable Effects with ChemoradiationYifan Wang, Hui Liu, Lixia Diao, et al.
Cell Death & Disease|September 12, 2014
UDP glucuronosyltransferase 1A expression levels determine the response of colorectal cancer cells to the heat shock protein 90 inhibitor ganetespibH Landmann, D A Proia, S He, et al.
Plos One|December 5, 2014
Inhibiting heat shock protein 90 (HSP90) limits the formation of liver cysts induced by conditional deletion of Pkd1 in miceZachary B Smithline, Anna S Nikonova, Harvey H Hensley, et al.
Pageof 9